中国实用儿科杂志2026，Vol.41Issue(6)：460-473,14.DOI:10.19538/j.ek2026060603
β2受体激动剂在儿童呼吸系统疾病中合理应用专家共识(2026)
Expert consensus on the rational application of β2 receptor agonists in children's respiratory diseases(2026)
中华医学会儿科学分会呼吸学组 1中国医师协会儿科医师分会呼吸专业委员会 1中国药学会儿童药物专业委员会 1中国妇幼保健协会儿童变态反应专委会呼吸学组 1《中国实用儿科杂志》编辑委员会 1陆权 1李智平 1张海邻1
作者信息
摘要
Abstract
β2 receptor agonists are one of the commonly used drugs for treating respiratory diseases in children,playing a significant role in the treatment of asthma and other wheezing disorders.To promote their standardized use,the Respiratory Group of the Pediatric Branch of the Chinese Medical Association,together with multidisciplinary experts,developed the"Expert Consensus on the Rational Application of β2 Receptor Agonists in Children's Respiratory Diseases(2026)"in accordance with the"Guidelines for Formulating and Revising Clinical Diagnosis and Treatment Guidelines in China(2022 edition)".This consensus reviews the pharmacological knowledge and proposes 8 clinical questions and 18 recommendations based on the"5R"framework of rational drug use,aiming to guide pediatricians,general practitioners,and clinical pharmacists at all levels in medical institutions to use β 2 receptor agonists rationally in children's respiratory diseases.关键词
β2受体激动剂/呼吸疾病/合理用药/儿童Key words
β2 receptor agonists/respiratory diseases/rational drug use/child分类
医药卫生引用本文复制引用
中华医学会儿科学分会呼吸学组,中国医师协会儿科医师分会呼吸专业委员会,中国药学会儿童药物专业委员会,中国妇幼保健协会儿童变态反应专委会呼吸学组,《中国实用儿科杂志》编辑委员会,陆权,李智平,张海邻..β2受体激动剂在儿童呼吸系统疾病中合理应用专家共识(2026)[J].中国实用儿科杂志,2026,41(6):460-473,14.
